Sophocarpine
- 2 independent labs in 1 country
- Funders: Jiangsu Commission of Health and 1 more
- Animals2
Outcomes
2Kidney fibrosis
downin mice1
1 study
Kidney fibrosis
downin mice1
Sophocarpine decreases kidney fibrosis in mice.
“sophocarpine ameliorates renal fibrosis and preserves function in D-galactose-induced progeroid mice by restoring autophagy”
Animalsin D-galactose-induced progeroid micekidney
LAPTM5 Promotes Age-Related Renal Fibrosis via USP10/PTEN-Mediated Autophagy Inhibition
FASEB journal : official publication of the Federation of American Societies for Experimental Biology18 May 2026
Intestinal fibrosis
downin mice1
1 study
Intestinal fibrosis
downin mice1
Sophocarpine decreases intestinal fibrosis in mice.
“SPC alleviates the inflammatory response, improves intestinal fibrosis and maintains intestinal mucosal homeostasis in vivo.”
Animalsin DSS-induced UC mice
European journal of pharmacology1 Feb 2024
Latest
1 in 12 monthsFASEB Journal
LAPTM5 Promotes Age-Related Renal Fibrosis via USP10/PTEN-Mediated Autophagy Inhibition
Experiments in miceKidney
bioRxiv
Qing-Luo-Yin-induced SIRT1 inhibition contributes to the immune improvement of adjuvant-induced arthritis rats
Preprint: experiments in animalsInterventions
European Journal of Pharmacology
Sophocarpine alleviates intestinal fibrosis via inhibition of inflammation and fibroblast into myofibroblast transition by targeting the Sirt1/p65 signaling axis
Experiments in miceGut and microbiome